Clinuvel Pharmaceuticals is under Algo Engine buy conditions. Company revenues increased 47% in FY21, helping to boost profits by nearly two-thirds to $24.7 million. The revenues were powered by strong patient demand in Europe and the US.
You're not a member! Trial today
